Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

The politics of Ecstasy.

Grob CS.

J Psychoactive Drugs. 2002 Apr-Jun;34(2):143-4. Review. No abstract available.

PMID:
12691204
2.

Ecstasy: America's new "reefer madness".

Rosenbaum M.

J Psychoactive Drugs. 2002 Apr-Jun;34(2):137-42. Review.

PMID:
12691203
3.

Ecstasy: dangers and controversies.

Pham JV, Puzantian T.

Pharmacotherapy. 2001 Dec;21(12):1561-5. Review.

PMID:
11765306
4.

[MDMA ("Ecstasy")--a dangerous drug or psychotherapeutic drug?].

Szukaj M.

Nervenarzt. 1994 Nov;65(11):802-5. Review. German.

PMID:
7816160
5.

[MDMA or ecstasy: pharmacologic, toxicologic and clinical aspects].

Prada C, Alvarez FJ.

Med Clin (Barc). 1996 Oct 26;107(14):549-55. Review. Spanish. No abstract available.

PMID:
8999216
6.

The irrelevance of research to government policies on drugs.

Bell DS.

Drug Alcohol Depend. 1990 Apr;25(2):221-4. Review. No abstract available.

PMID:
2183989
7.

Club drugs: is it all ecstasy?

Tellier PP.

Pediatr Ann. 2002 Sep;31(9):550-6. Review. No abstract available.

PMID:
12271739
8.

Illegal drug use and public policy.

Grossman M, Chaloupka FJ, Shim K.

Health Aff (Millwood). 2002 Mar-Apr;21(2):134-45. Review.

9.

Fifteen solutions to the problems of prescription drug abuse.

Lurie P, Lee PR.

J Psychoactive Drugs. 1991 Oct-Dec;23(4):349-57. Review.

PMID:
1813607
10.

Preventing problems in Ecstasy users: reduce use to reduce harm.

Baggott MJ.

J Psychoactive Drugs. 2002 Apr-Jun;34(2):145-62. Review.

PMID:
12691205
11.

MDMA misrepresentation: an unresolved problem for Ecstasy users.

Hayner GN.

J Psychoactive Drugs. 2002 Apr-Jun;34(2):195-8. Review.

PMID:
12691209
12.

Drug information systems, early warning, and new drug trends: can drug monitoring systems become more sensitive to emerging trends in drug consumption?

Griffiths P, Vingoe L, Hunt N, Mounteney J, Hartnoll R.

Subst Use Misuse. 2000 May-Jun;35(6-8):811-44. Review.

PMID:
10847213
13.

[Effects of ecstasy on the body].

Saarijärvi S, Lopperi M.

Duodecim. 2003;119(13):1211-5. Review. Finnish. No abstract available.

PMID:
12908183
14.

Barcelona meeting on clinical testing of drug abuse liability: consensus statement and recommendations.

[No authors listed]

Br J Addict. 1991 Dec;86(12):1527-8. Review. No abstract available.

PMID:
1786481
15.

[Morbidity and mortality caused by use of ecstasy].

de Man RA.

Ned Tijdschr Geneeskd. 1994 Sep 10;138(37):1850-5. Review. Dutch. No abstract available.

PMID:
7935920

Supplemental Content

Support Center